Abstract 1488P
Background
Patients with advanced cancer often experience distressing symptoms between appointments, leading to unplanned admissions and emergency room visits. The SUPPORT+ mobile app was developed to improve symptom monitoring and clinical support for these patients. This study aims to assess the feasibility and acceptability of the SUPPORT+ mobile app for monitoring symptoms and providing interventions in advanced cancer patients.
Methods
Patients in palliative care downloaded the app and used it for symptom monitoring weekly with remote advice from palliative nurses for 16 weeks. Feasibility was assessed based on app usage and retention rates. Outcomes were compared at baseline and week 16.
Results
Out of 109 participants (55.1% male, median age 68.7 years), 84 completed the study. During the study period, 16 patients passed away. Among the remaining participants, 76 actively used the SUPPORT+ app for weekly symptom reporting, receiving remote support from palliative nurses. The retention rate was 81.7%. Home exercise and cancer myths were the most accessed app domains. Comparing baseline and week 16 data, a significant increase was observed in completion of advanced directive (AD) (11.0% vs. 14.1%, p=0.046) and discussion on the preferred place of dying (27.3% vs. 32.1%, p=0.041). Furthermore, anxiety scale scores significantly decreased in week 16 compared to baseline (mean 6.5 vs. 5.7, p=0.024). There were no significant differences in emergency room visits, depression scale scores, or palliative care knowledge between baseline and week 16. Most participants (92.8%) reported the app as easy to use, indicating a high level of acceptance and usability. Additionally, 71.1% mentioned that the app positively influenced their health habits.
Conclusions
The SUPPORT+ app demonstrated feasibility and acceptability in facilitating end-of-life communication, increasing AD completion, and potentially reducing anxiety in advanced cancer patients. Further research is needed to explore its long-term efficacy in larger randomized controlled trials.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1199P - Developing and systematically validating homologous recombination repair gene detection method based on next-generation sequencing
Presenter: Yi Sun
Session: Poster session 10
1200P - Investigation of multiphoton microscopy as an innovative tool for intraoperative section-free histologic investigations in just a few minutes
Presenter: Martí Homs Soler
Session: Poster session 10
1201P - Novel deep learning model and validation of whole slide images in lung cancer diagnosis
Presenter: Alhassan Ahmed
Session: Poster session 10
Resources:
Abstract
1202P - A deep learning approach using routine pathology images to guide precision medicine in metastatic CRC
Presenter: Chaitanya Parmar
Session: Poster session 10
1203P - Analytical evaluation of whole genome sequencing for acute myeloid leukemia
Presenter: Guidantonio Malagoli Tagliazucchi
Session: Poster session 10
1204P - Real-world utility of whole genome sequencing for patients with cancer: Evaluation of a regional implementation of the 100,000 genomes project
Presenter: Helen Robbins
Session: Poster session 10
1205P - A retrospective machine learning-based analysis of nationwide cancer CGP data across cancer types to identify features associated with recommendation of mutation-based therapy
Presenter: Hiroaki Ikushima
Session: Poster session 10
1478P - Dual single-nucleotide polymorphism biomarker combination to select opioid for cancer pain management
Presenter: Yoshihiko Fujita
Session: Poster session 10
1479P - Use of rescue opioids and pain control after ketamine initiation in refractory cancer pain: A multicentric observational study
Presenter: Pablo Gallardo Melo
Session: Poster session 10
1480P - Long term therapy with denosumab and zoledronic acid: A comparative real-world retrospective observational study on skeletal-related events and pain in patients with metastatic breast cancer
Presenter: Giacomo Massa
Session: Poster session 10